AU6366000A - Multidrug resistance pump inhibitors and uses thereof - Google Patents

Multidrug resistance pump inhibitors and uses thereof

Info

Publication number
AU6366000A
AU6366000A AU63660/00A AU6366000A AU6366000A AU 6366000 A AU6366000 A AU 6366000A AU 63660/00 A AU63660/00 A AU 63660/00A AU 6366000 A AU6366000 A AU 6366000A AU 6366000 A AU6366000 A AU 6366000A
Authority
AU
Australia
Prior art keywords
multidrug resistance
pump inhibitors
resistance pump
inhibitors
multidrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63660/00A
Inventor
Nathan R. Guz
Kim Lewis
Peter Lorenz
Frank R. Stermitz
Jeanne N. Tawara-Matsuda
Lauren Zenewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colorado State University Research Foundation
Tufts University
Original Assignee
Colorado State University Research Foundation
Tufts University
Colorado State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colorado State University Research Foundation, Tufts University, Colorado State University filed Critical Colorado State University Research Foundation
Publication of AU6366000A publication Critical patent/AU6366000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU63660/00A 1999-07-23 2000-07-21 Multidrug resistance pump inhibitors and uses thereof Abandoned AU6366000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14547499P 1999-07-23 1999-07-23
US60145474 1999-07-23
PCT/US2000/020001 WO2001007034A1 (en) 1999-07-23 2000-07-21 Multidrug resistance pump inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
AU6366000A true AU6366000A (en) 2001-02-13

Family

ID=22513282

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63660/00A Abandoned AU6366000A (en) 1999-07-23 2000-07-21 Multidrug resistance pump inhibitors and uses thereof

Country Status (2)

Country Link
AU (1) AU6366000A (en)
WO (1) WO2001007034A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079257A2 (en) * 2000-04-14 2001-10-25 Phytera, Inc. Multidrug resistance (mdr) efflux pump polypeptides
US7011957B2 (en) 2001-09-26 2006-03-14 Northeastern University Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon
EP1591112A4 (en) * 2003-02-04 2006-06-14 Yakult Honsha Kk Breast cancer-resistant protein inhibitor
EP2014651A1 (en) * 2007-07-12 2009-01-14 Exonhit Therapeutics SA Compounds and methods for modulating Rho GTPases
US11566260B2 (en) 2012-07-16 2023-01-31 Universite D'angers Potentiating agents for protecting plants from fungal infections
EP2687097A1 (en) * 2012-07-16 2014-01-22 Universite D'angers Potentiating agents for protecting plants from fungal infections
US20150322033A1 (en) * 2012-11-13 2015-11-12 Juntendo Educational Foundation Antibacterial agent
CN106794158A (en) * 2014-05-30 2017-05-31 劳伦斯·T·弗里霍夫 Antimicrobial pharmceutical compositions with multiple drug resistance inhibition activity
BR112020025126A2 (en) * 2018-06-09 2021-03-23 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. compounds for the treatment or prevention of liver disease
CN109364071A (en) * 2019-01-02 2019-02-22 李萍 A kind of drug and purposes promoting salivary secretion treatment xerostomia syndrome
CN110639017A (en) * 2019-09-19 2020-01-03 安徽中医药大学 Pharmaceutical composition for inhibiting candida albicans
CN114105963B (en) * 2021-12-16 2023-08-18 贵州大学 Anti-tubercle bacillus compound and preparation method and application thereof
CN116270489B (en) * 2023-03-22 2023-09-08 遵义市中医院 Ginger stomach-activating granule and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950700061A (en) * 1992-02-06 1995-01-16 스티븐 엘. 네스비트 REVERSAL OF MULTI -DRUG RESISTANCE BY TETRAARYLETHYLENES
KR100377280B1 (en) * 1993-01-21 2003-07-18 메렐 파마슈티칼스 인크. Multi-drug resistant tumor therapeutic efficacy-enhancing pharmaceutical composition containing diarylalkylpiperidine
US5763443A (en) * 1994-04-05 1998-06-09 Universiteit Van Pretoria MDR resistance treatment and novel pharmaceutically active riminophenazines
JPH107559A (en) * 1996-06-18 1998-01-13 Kureha Chem Ind Co Ltd Suppressant for synthesis of protein belonging to hsp27 family containing berberine derivative

Also Published As

Publication number Publication date
WO2001007034A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
AU5560600A (en) Running and testing applications
AU6758800A (en) Pump systems and methods
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU5826100A (en) Benzazepinones and quinazolines
AU2002218182A1 (en) Adhesives having barrier properties
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU1540001A (en) Fluorene-perylene copolymers and uses thereof
AU2001275286A1 (en) Transdermal delivery
AU2002211717A1 (en) Stresscopins and their uses
AU3155501A (en) Spreading factor determination
AUPQ008399A0 (en) Cariovascular applications
AU6366000A (en) Multidrug resistance pump inhibitors and uses thereof
AU2002216649A1 (en) Benzoxazole lpaat- beta inhibitors and uses thereof
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2003281620A1 (en) Copolymer and polymeric luminescent element comprising the same
AU2003299943A1 (en) Heterocycles and uses thereof
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU4052200A (en) Multidrug resistance associated proteins and uses thereof
AUPQ872300A0 (en) Compounds and methods
AU3732500A (en) Beclin and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase